Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today. Understanding the reality of the European drug market requires a holistic approach, following the supply chain from production and trafficking to distribution and use.
Taking such an approach, two EU agencies — the EMCDDA and Europol — have joined forces to provide their latest overview of the European illicit market for two stimulant drugs: cocaine and methamphetamine.
To be presented in Brussels on 6 May, the analyses combine data from the EMCDDA’s drug monitoring system with Europol’s operational intelligence on organised crime.
These are the first in a series of online modules exploring the EU drug market. Further modules will be published in 2023 to complete the strategic analysis. These will cover amphetamine, cannabis, heroin, MDMA and new psychoactive substances, as well as impacts, drivers and responses.
Date: 6 May 2022
Time: 10.30 Central European Time (CET/Brussels), 09.30 (WEST/Lisbon)
Venue: Résidence Palace, 155 Rue de la Loi, B-1040 Brussels (Polak room)
On 6 May, our experts will be available for comment on these market analyses.
In Brussels, at the press conference, the following experts will be available for interviews:
Tel. (351) 211 21 02 00 (in Lisbon, EMCDDA, Leonor Gomes).
Tel. (351) 935 994 027 (in Brussels, Kathryn Robertson).